Characterization of the human endothelial nitric-oxide synthase promoter - Wikidata - wikimedia - TriplyDB

Characterization of the human endothelial nitric-oxide synthase promoter

Characterization of the human endothelial nitric-oxide synthase promoter

http://www.wikidata.org/entity/Q28294946

about

Fetal Alz-50 clone 1 (FAC1) protein interacts with the Myc-associated zinc finger protein (ZF87/MAZ) and alters its transcriptional activity Role of the 3'-untranslated region of human endothelin-1 in vascular endothelial cells. Contribution to transcript lability and the cellular heat shock response An alternative promoter of the human neuronal nitric oxide synthase gene is expressed specifically in Leydig cells Quantitative proteomic identification of MAZ as a transcriptional regulator of muscle-specific genes in skeletal and cardiac myocytes Molecular cloning and functional characterization of the transcription factor YY2.MRG1 expression in fibroblasts is regulated by Sp1/Sp3 and an Ets transcription factor.Transcriptional regulation of human eosinophil RNases by an evolutionary- conserved sequence motif in primate genome.Differential roles for ETS, CREB, and EGR binding sites in mediating VEGF receptor 1 expression in vivo.Hypoxic repression of endothelial nitric-oxide synthase transcription is coupled with eviction of promoter histones Association of eNOS and HSP70 gene polymorphisms with glaucoma in Pakistani cohorts.Estrogen-related receptor alpha 1 up-regulates endothelial nitric oxide synthase expression.Concerted actions of renal endothelial and macula densa NO systems in the maintenance of extracellular fluid volume.Activation of AP-1 transcription factors differentiates FGF2 and vascular endothelial growth factor regulation of endothelial nitric-oxide synthase expression in placental artery endothelial cells.RhoJ is an endothelial cell-restricted Rho GTPase that mediates vascular morphogenesis and is regulated by the transcription factor ERG.Ets target genes: past, present and future.The KRAS promoter responds to Myc-associated zinc finger and poly(ADP-ribose) polymerase 1 proteins, which recognize a critical quadruplex-forming GA-element G4-DNA formation in the HRAS promoter and rational design of decoy oligonucleotides for cancer therapy.Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase.Laminar shear stress modulates phosphorylation and localization of RNA polymerase II on the endothelial nitric oxide synthase gene Regulation of gene expression by internal ribosome entry sites or cryptic promoters: the eIF4G story Association of genetic polymorphisms of eNOS with glaucoma.Epigenetics of Cardiovascular Disease - A New "Beat" in Coronary Artery Disease.Endothelial dysfunction in children with obstructive sleep apnea is associated with epigenetic changes in the eNOS gene An intronic miRNA regulates expression of the human endothelial nitric oxide synthase gene and proliferation of endothelial cells by a mechanism related to the transcription factor SP-1 Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase.Synthetic promoter elements obtained by nucleotide sequence variation and selection for activity.DNA methylation in the arginase-nitric oxide synthase pathway is associated with exhaled nitric oxide in children with asthma.EZH2 modulates angiogenesis in vitro and in a mouse model of limb ischemia.Genomewide association study using a high-density single nucleotide polymorphism array and case-control design identifies a novel essential hypertension susceptibility locus in the promoter region of endothelial NO synthase.Functional expression of endothelial nitric oxide synthase fused to green fluorescent protein in transgenic mice.Lysophosphatidylcholine up-regulates human endothelial nitric oxide synthase gene transactivity by c-Jun N-terminal kinase signalling pathway Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension Mucin biosynthesis: identification of the cis-regulatory elements of human C2GnT-M gene.Differential transcription factor use by the KIR2DL4 promoter under constitutive and IL-2/15-treated conditions.Relative reduction of endothelial nitric-oxide synthase expression and transcription in atherosclerosis-prone regions of the mouse aorta and in an in vitro model of disturbed flow.No difference in genotype frequencies of polymorphisms of the nitric oxide pathway between Caucasian normal and high tension glaucoma patients.Particulate matter, DNA methylation in nitric oxide synthase, and childhood respiratory disease.Transcriptional regulation of endothelial nitric oxide synthase expression in uterine artery endothelial cells by c-Jun/AP-1.Nitric oxide and hormones in breast cancer: allies or enemies?

P2860

Q22253366-ACB3D47C-9E0D-487E-B8B6-F088D0B9E8AA Q28189925-97400145-7379-461D-A4AE-5900F63E1769 Q28344824-3D0676BD-1886-4B95-B10D-767A5FF29C88 Q28592770-4AE0977D-643A-42E7-A2A1-DE6619F04FCF Q31814848-1D72DB38-7518-417E-836D-33CA03592B83 Q31835215-F5AE81F7-DE3C-4DB1-888E-1AC9F74D4191 Q33302220-C4A31D4D-CB57-483C-9BF7-FD2A3BAFDD8D Q33560441-3888F5EF-40B4-4B84-82E5-227181335C2A Q33569829-752F4180-2BFD-4752-BF9C-1591CDFCF064 Q33586390-6146C158-9BAF-4042-951C-1FE16DCD291F Q33717777-34D43594-2EB7-4EE5-BAEF-CF82F40B2074 Q33848411-048B5B74-DFE5-4562-B04C-51EE7E347388 Q33885073-AD3A059B-9F8C-43CD-B173-639FF7DBA4FC Q33917875-0D1F3980-3859-450B-B5DC-C9D782239E3D Q33933227-7D4894AF-C3C9-428E-AA39-8BFCC4CC33B1 Q33991095-1ABDCB43-3A76-473E-B908-05B1E9EBFB98 Q34023514-80777362-EC25-4B09-A8C1-446943B860EF Q34131621-FA916BA9-ED19-4DF2-9F0B-E042D8CEAE04 Q34169180-77032EF8-C463-4462-A00E-4C5B91E1588C Q34325611-3D926949-6D18-4D46-B2F8-8DC52484DD1C Q34493805-4DD137AE-9DE3-4B06-BCBB-3DB6A52DC4D3 Q34516737-6F4EA696-2022-4A87-9227-495E160DB880 Q34553225-F765B36C-382B-445D-87C7-837CF561CEB4 Q34935589-57F00E7A-454D-46C6-8DB8-FF9A3A99739C Q35026148-90DEC7F9-5C7C-4571-A5DE-3889E90B77AC Q35103817-38231FA9-3103-45CE-AA0D-39EB922006F1 Q35212586-966C25FA-3847-4590-B2D0-D0772DB99686 Q35591404-7C840149-508F-4321-9E68-0FE5CCCD056A Q35737993-ECEE556E-373F-48AA-A7AA-603EF7CEE94F Q35792234-CC4D6D11-3233-4665-864B-20942EF1A844 Q35832000-8ACCD168-AFE5-4689-ACC3-757172C840F5 Q35849576-742C5631-CB95-4BD7-8752-9EDA882DA81F Q35850320-A987FD33-994C-4FDA-9330-54E164AAC98E Q35855334-B58BD57A-F7F3-4C1F-A6BF-AF94881B33D7 Q35903235-C38947A8-DCA0-4F13-9F7D-D5C03BA25E2A Q36095665-CE088D64-7EBC-40B6-A131-16FC607F3686 Q36182942-53E843AF-B756-4ABF-8B4D-93D582EE3784 Q36229151-DADF2F70-B0A1-41FD-95A9-717A384A5C0E Q36253545-E5B90B60-A934-459D-B4CD-8F844A7E73F6 Q36430756-915DDD41-1AB0-45B9-98C1-D326E762BBA4

P2860

Characterization of the human endothelial nitric-oxide synthase promoter

http://www.wikidata.org/entity/Q28294946

description

1999 nî lūn-bûn

@nan

1999 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Characterization of the human endothelial nitric-oxide synthase promoter

@ast

Characterization of the human endothelial nitric-oxide synthase promoter

@en

Characterization of the human endothelial nitric-oxide synthase promoter

@nl

type

label

Characterization of the human endothelial nitric-oxide synthase promoter

@ast

Characterization of the human endothelial nitric-oxide synthase promoter

@en

Characterization of the human endothelial nitric-oxide synthase promoter

@nl

prefLabel

Characterization of the human endothelial nitric-oxide synthase promoter

@ast

Characterization of the human endothelial nitric-oxide synthase promoter

@en

Characterization of the human endothelial nitric-oxide synthase promoter

@nl

P1433

Q28294946-8D6F6C9C-7B9D-41E3-BA09-2FF2377B13FD

P1476

Q28294946-55160FC5-613A-4489-9F64-D3741887A3D3

P2093

Q28294946-1C801D71-A1A8-49FC-B3C6-3F722A74079B

Q28294946-3FAC4ED7-28A4-4EBE-9AFC-B38B42CC6495

Q28294946-440851DE-F2EB-4022-9533-9B1F4C671E00

Q28294946-683EF866-2CE5-4BC5-BEC2-3BA65265A431

Q28294946-7405DE20-99C5-4802-8497-A882EE660624

Q28294946-7A440C9F-87AA-4809-A72D-6F19233FBC3A

Q28294946-AE780912-CA91-4B1D-B398-E64092B6CF6B

Q28294946-B4407007-5DF9-4287-94C2-ABDCE2601CEE

Q28294946-CA5D3C18-089A-48A5-8140-C76571D0961A

Q28294946-CCF7A4E1-F29C-41B8-98FC-709F0851DDCE

P2860

Q28294946-0211FB8C-B203-4854-8A45-096F1414C2C8

Q28294946-060C5DB2-2588-4F85-B992-A60A300E3EB8

Q28294946-0923DAB2-EE9F-4BA9-8816-462205A432BC

Q28294946-0B6E7DB9-0A56-4471-A0B5-6906B72C958D

Q28294946-12BDC272-44A9-40AF-A1C9-21B14A090DE1

Q28294946-12F585A8-0D75-41DE-8A49-0DF55BA7D602

Q28294946-14D14E69-845E-4589-A3C3-034A1F199AF9

Q28294946-15457D4E-F668-4D50-80FE-DD4268040054

Q28294946-15E71B89-0B59-43AF-92AE-B8B44B7C5AD7

Q28294946-16C4F02A-C9CD-4E01-BAF6-8AF7D4446391

P304

Q28294946-6266EF08-AFCC-4145-8BFC-F2A8090B61ED

P31

Q28294946-C017CB99-0EE9-4A0D-A49C-A4D81203C87C

P3181

Q28294946-9E58685B-B7E8-4AAF-A902-3541E146F1BF

P356

Q28294946-EF8E8468-6E1F-49B4-9437-9AB948B0804E

P407

Q28294946-8790ADA9-C668-4FBD-974C-EE7F9566147C

P433

Q28294946-731714D6-D005-4244-8257-177D5EAED611

P478

Q28294946-DF00904C-75B0-4614-A47A-1BCFCE2CF4D4

P577

Q28294946-A21B259F-1341-4BBB-8608-D63980B3FCE8

P5875

Q28294946-C114BB1C-320B-4572-AF17-2BF9322E1BAB

P698

Q28294946-ED5C9341-05E3-4073-B41A-3361703CC1D4

P921

Q28294946-35AF6620-E318-4E4E-B2D8-E842623835DB

P3181

P356

P1433

Journal of Biological Chemistry

P1476

Characterization of the human endothelial nitric-oxide synthase promoter

@en

P2093

C D'Abreo

http://www.w3.org/2001/XMLSchema#string

F Karantzoulis-Fegaras

http://www.w3.org/2001/XMLSchema#string

G K Wong

http://www.w3.org/2001/XMLSchema#string

G Kulkarni

http://www.w3.org/2001/XMLSchema#string

H Antoniou

http://www.w3.org/2001/XMLSchema#string

J Atkins

http://www.w3.org/2001/XMLSchema#string

P A Marsden

http://www.w3.org/2001/XMLSchema#string

S L Lai

http://www.w3.org/2001/XMLSchema#string

T L Miller

http://www.w3.org/2001/XMLSchema#string

Y Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of NERF, a novel transcription factor related to the Ets factor ELF-1

MAZ, a zinc finger protein, binds to c-MYC and C2 gene sequences regulating transcriptional initiation and termination

Isolation and characterization of a novel epithelium-specific transcription factor, ESE-1, a member of the ets family

Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1

Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3

Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins

A new pattern for helix-turn-helix recognition revealed by the PU.1 ETS-domain-DNA complex

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

Molecular cloning and characterization of human endothelial nitric oxide synthase

The serotonin 1a receptor gene contains a TATA-less promoter that responds to MAZ and Sp1

P304

3076-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1789094

http://www.w3.org/2001/XMLSchema#string

P356

10.1074/JBC.274.5.3076

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

274

http://www.w3.org/2001/XMLSchema#string

P577

1999-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13372989

http://www.w3.org/2001/XMLSchema#string

P698

9915847

http://www.w3.org/2001/XMLSchema#string

P921